StemCell Therapy

New York, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pyrethrin Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Pest Types, Application" - https://www.reportlinker.com/p05967903/?utm_source=GNW Pyrethrin is widely used in veterinary medicine for agricultural and domestic purposes. It is used for the treatment of ectoparasites in large and small animals and also in non-mammalian species such as birds, fish, and honeybees. It is used in veterinary medicine in various formulations, including spot-on, sprays, ear tags, soluble powders, and dips. Synthetic pyrethroids have been classified into two types, mainly type I and type II. It is observed that the addition of the alpha-cyano group to the 3-phenoxylbenzyl alcohol group in type II and increased the insecticidal potency. Pyrethrin and piperonyl butoxide together come in the form of a shampoo that is applied to the skin and hair. It is applied in two to three treatments to treat lice. Pyrethrin is also used in body lice medicines such as A-200, Pyrinate, Barc, Lice-Enz, Licetrol, Pronto, Tisit, Tisist blue and Tripple X. The medical application of Pyrethrin is yet another factor bolstering well the demand for pyrethrin all across the globe.

Based on pest type, the pyrethrin market has been segmented into mites, lepidoptera, coleoptera, coleoptera, diptera, and others.In 2019, the diptera dominated the market with the largest share.

The diptera or true flies include insects, such as midges, mosquitoes, sandflies, blowflies, and houseflies.The class of diptera flies contaminates the food and spreads diseases such as typhoid, malaria, and cholera.

The dipteran larvae are legless.They live in aquatic, semi-aquatic, or moist terrestrial environments.

Pyrethrin, as an insecticide, is highly capable of directly impacting the nervous system of diptera flies. This kills them directly or ends up harming their reproductive systems. Rise in adoption rate of pyrethrin as an insecticide due to its strong and life threatening effects on diptera has favored the global pyrethrin market.

In 2019, North America held the largest share of global pyrethrin market in 2019.Demand for pyrethrin in the region is expected to increase due to rise in requirement of hygiene products in the household sector.

Changing lifestyle, increase in population, and rise in disposable income of consumers favors the pyrethrin market in North America.Moreover, the high potency and effectiveness of pyrethrin as a vital ingredient in household and industrial sector also drives the market growth.

New investments and marketing strategies by manufacturers have also fueled the demand for pyrethrin in North America.Increase in cases of dengue fever and yellow fever have raised the need for pyrethrin in the region.

Inclination toward the use of organic products is yet another factor that favors the pyrethrin market in North America.

COVID-19 pandemic has been affecting economies and industries in various countries, including the US, Brazil, Russia, India, Italy, the UK, Iran, and Spain.Chemicals and materials is one the worlds major industries suffering serious disruptions in the form of supply chain breaks, event cancellations, and office shutdowns as a result of the lockdowns imposed in various countries to contain the disease spread.

China is the global manufacturing hub and largest raw material supplier for various industries; it is also one of the worst-affected countries by the COVID-19 pandemic.The lockdown of various plants and factories in China is affecting the global supply chains and adversely impacting the manufacturing and sales of various chemical and materials.

These factors are likely to restrain the growth of various markets related to the chemicals and materials industry in next few financial quarters.

A few key players present in the global pyrethrin market are Botanical Resources Australia Pty Ltd.; China Xian Nutrendhealth Biotechnology Co., Ltd.; Endura; Zhejiang Rayfull Chemicals Co., Ltd.; Pestech Australia Pty Ltd.; Scintex; Horizon Sopyrwa; Kapi Limited; and Zhengzhou Delong Chemical Co., Ltd; among others.

The overall global pyrethrin market size has been derived using both primary and secondary source.The research process begins with exhaustive secondary research using internal and external sources to obtain qualitative and quantitative information related to the pyrethrin market.

Also, multiple primary interviews were conducted with industry participants and commentators in order to validate data and analysis. The participants who typically take part in such a process include industry experts, such as VPs, business development managers, market intelligence managers, and national sales managers, and external consultants, such as valuation experts, research analysts, and key opinion leaders specializing in the pyrethrin market.Read the full report: https://www.reportlinker.com/p05967903/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

See more here:
Pyrethrin Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Pest Types, Application - GlobeNewswire

New Jersey, United States, The Veterinary Medicine Market report 2020 provides a detailed impression, describe the product industry scope and the market expanded insights and forecasts up to 2027. It shows market data according to industry drivers, restraints and opportunities, analyzes the market status, the industry share, size, future Trends and growth rate of the market. The Veterinary Medicine Market report is categorized by application, end user, technology, product / service types, and other, as well as by region. In addition, the report includes the calculated expected CAGR of chitosan acetate-market derivative from the earlier records of the Veterinary Medicine Market, and current market trends, which are organized with future developments.

The Global Veterinary Medicine Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2019 to 2026.

Download full PDF example copy of Veterinary Medicine Market report: (including Full Toc, list of tables and numbers, graph): https://www.verifiedmarketresearch.com/download-sample/?rid=21894&utm_source=TDC&utm_medium=001

Global Veterinary Medicine Market, By Product

OralInjectionOther

Global Veterinary Medicine Market, By Application

Companion AnimalsLivestock Animals

The report provides detailed coverage of the Veterinary Medicine Market, including structure, definitions, applications, and Industry Chain classifications. The Veterinary Medicine Market analysis is provided for the international markets including development trends, competitive landscape analysis, investment plan, business strategy, opportunities and development status of key regions. Development policies and plans are discussed and manufacturing processes and cost structures analyzed. This report also includes information on import / export consumption, supply and demand, costs, industry share, policy, Price, Sales and gross margins.

Ask For Discount @https://www.verifiedmarketresearch.com/ask-for-discount/?rid=21894&utm_source=TDC&utm_medium=001

Veterinary Medicine Market forecast up to 2027, with information such as company profiles, product picture and specification, capacity production, price, cost, revenue, and contact information. Upstream raw materials and equipment as well as downstream demand analyses are also carried out. The Veterinary Medicine Market size, development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed and general research results are offered.

The Veterinary Medicine Market was created on the basis of an in-depth market analysis with contributions from industry experts. The report covers the growth prospects in the coming years and the discussion of the main providers.

To understand how the effects of COVID-19 are addressed in this report. A sample copy of the report is available at https://www.verifiedmarketresearch.com/product/Veterinary-Medicine-Market/?utm_source=TDC&utm_medium=001

Verified Market Researchis a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email:[emailprotected]

Read the original post:
Veterinary Medicine Market is Thriving Worldwide 2020 | Trends, Growth and Profit Analysis, Forecast by 2027 - The Daily Chronicle

ASHLAND -- Destiny LaFever has been named Ashland Elks Teen of the Month for September. Destiny is the daughter of Mark and Kristine LaFever and is a member of the Class of 2021 at Crestview High School.

LaFever is active in a variety of school activities including varsity soccer, basketball, softball choir and FFA. Her leadership positions include student council, National Honor Society, and FFA vice-president.

Outside of school, she is involved in 4-H. LaFever was the recipient of the 2020 Ashland County 4-H I Dare You award and the Market Steer Ultimate Exhibitor award. She enjoys showing market steers and market hogs at the Ashland County Fair as well as at the State Fair and Jackpot shows.

LaFever is employed at the Claremont Veterinary Clinic where she enjoys working with the animals and being able to help nurse them back to health.

After graduation, she plans to attend the Ohio State ATI campus for a year and then transfer to The Ohio State University main campus to major in animal science/ pre-veterinary medicine. She then hopes to attend The Ohio State University College of Veterinary Medicine and becoming the third generation veterinarian in her family.

The most important part of education comes from the support of those outside the classroom. Being informed is the first step. Your support does that for the entire community we share.

Read more:
Crestview's LaFever chosen by Ashland Elks as Teen of the Month - Richland Source

Vanessa Ezenwa, UGA Athletic Association Professor of Ecology, thinks bigand also really, really small.

A professor in the Odum School of Ecology and College of Veterinary Medicine department of infectious diseases, Ezenwas research integrates perspectives that range from the microbial to the ecosystem scale. Her work explores the ways that parasites influence the social behavior of large mammals and how that social behavior in turn influences parasite transmission. Her goal is to understand how those dynamics affect not only individuals but entire populations and communities of both parasites and hosts. And while she generally studies ungulates, her findings have implications for human health, as well.

Ezenwa, a recipient of a CAREER award from the National Science Foundation who came to UGA from the University of Montana in 2010, didnt set out to study the relationships between parasite transmission and social behavior in animals. As an undergraduate biology major at Rice University, her plan was to attend medical schooluntil, that is, she had the chance to work in a lab that focused on animal behavior.

Since high school I was quite interested in infectious diseases as related to medicine, but working in that lab got me interested in ecology and evolution, she said. Fast forward, I decided to go to graduate school to study animal behavior. I got introduced to the idea that how animals were socially organized, the types and size of groups they lived in and how fluid those dynamics were, that those things were associated with the transmission of parasites, and in turn that parasites actually drive the evolution of social organization in animals.

Ezenwa did her doctoral research at Princeton University on African ungulates in Kenya, where many species overlapped in the same locations. Her dissertation focused on 11 species that varied from living singly or in pairs to living in groups of 100 or more.

It really gave me the range of social types to look at, but at the same time I realized theyre all living together and theyre grouping together, as well. They often transmit the same parasites amongst one another and are infected by multiple parasite species simultaneously, she said. That has really shaped a lot of my research ever since.

A major theme of her current work is understanding the effects of coinfection by more than one parasite and/or pathogen on individuals and populations. In particular, she is investigating how the immune response to one pathogen influences the outcome of infection to another.

This work is inspired by a lot of work in humans, where for a long time people have been interested in the effect of parasitic wormsbecause theyre so common in humans in some parts of the worldon diseases caused by microbes like tuberculosis-causing bacteria and HIV, and what the connections are, she said. Ive been fascinated by the fact that we can try to understand these ideas and the underlying mechanisms, and also how they influence large-scale population level patterns of pathogen spread, in wildlife, potentially more easily than we could ever understand it in humans.

Ezenwas interest in exploring these questions from the microbial to the community level led her to develop the Infectious Disease Ecology Across Scales (IDEAS) doctoral training program. With funding from the National Science Foundation, the program introduces students to the study of infectious diseases from multiple scales and disciplinary perspectives.

Our goal is to train up-and-coming scientists studying infectious diseases to appreciate cross-scale linkages, said Ezenwa. And by cross-scale, its really different levels of biological organization, from the smallest to the largest, and realizing that all of these steps along the hierarchy actually matter.

See the rest here:
Infectious diseases professor studies immune response - University of Georgia

Adtalem Global Education's plans to acquire Walden University, announced Friday, are part of an orchestrated push to become a national leader in health-care education.

Laureate Education will sell Walden University, a for-profit online institution that has for years stood out from Laureate's focus on emerging international markets, to Adtalem for $1.48billion. The transaction is expected to close mid-2021, pending regulatory approvals by the U.S. Department of Education and Walden's accreditor, the Higher Learning Commission.

Walden is one of the largest U.S. for-profit online institutions by student enrollment, according to federal data, following the University of Phoenix and Grand Canyon University -- although Grand Canyon disputes the U.S. Department of Education's decision to label it a for-profit for federal financial aid purposes.

Walden enrolls around 52,000 students, 78percent of whom are enrolled in health sciences programs, according to a university spokesperson. Walden offers more than 80 degree programs, mostly at the masters level, in areas such as education, business and public administration. It also offers programs leading to health-care professions such as nursing and mental health counseling.

Adtalem, formerly known as DeVry Education Group, sold online for-profit DeVry University to a small private company in 2017. The publicly traded company has amassed a significant portfolio of health care-focused institutions in recent years, including the American University of the Caribbean School of Medicine, Ross University School of Medicine, Ross University School of Veterinary Medicine and Chamberlain University, which bills itself as running the largest nursing school in the country across 22 campus locations.

The acquisition of Walden will ensure Adtalem is better positioned to increase the talent supply to address the rapidly growing and unmet demand for health care professionals in the U.S. and globally, the company said in a news release. Waldens program offerings and technology, its strong online capabilities, and its focus on diversifying the health care workforce are complimentary with Adtalems existing strengths as a leading health care workforce solutions provider and long track record of providing superior outcomes for students.

The combined institutions Adtalem will own will have 26 campuses in 15 states and four countries, the company said. They will have 6,100 faculty members and more than 90,000 students -- 34percent of whom are Black. The company claims it will be the world's top provider of M.D.s, Ph.D.s and nursing degrees to African Americans.

For Laureate Education, the sale marks a long-signaled departure from the U.S. higher education market. The publicly traded Baltimore-based company used to be well-known for its global campus network but sold off many of its international institutions to focus on the emerging higher education markets in South and Central America. Earlier this year, the company entered into a $642.7million agreement to sell three institutions in Australia and New Zealand to Strategic Education, the Minneapolis-based company behind Capella University and Strayer University.

Laureate Education has not been secretive about its desire to sell Walden. The company announced it was discussing a possible transaction with third parties in late 2018. In February 2019, the company said it had decided not to sell the university, stating that Laureate was best positioned to support Walden at that time. Then in January this year, Laureate indicated it was open to exploring "strategic alternatives for each of its businesses to unlock shareholder value" -- suggesting the university was again on the market.

The Walden acquisition is something Adtalem has desired for "some time," said Lisa Wardell, president and CEO of Adtalem, in an investor call on the deal last week. In the 12 months prior to June30, Walden University and associated company Walden e-Learning had approximately $591.3million in revenue and $146.5million in operating income, according to a recent U.S. Securities and Exchange Commission filing.

Whether anything will change at Walden University under Adtalems leadership is unclear. An Adtalem spokesperson said there will be no changes before the transaction is closed, and its too early to speculate beyond that time frame. In a letter to Walden University students, Ward Ulmer, the institutions president, said the sale does not change anything about your educational experience at Walden.

Both Walden and Adtalem have made it a priority that you continue to have the same strong academic programs and experience you have come to expect from our university, wrote Ulmer. The transfer of ownership does not affect your financial aid or Waldens TitleIV financial aid authorization. Walden will retain its current accreditations with the Higher Learning Commission, as well as all of its current programmatic and national accreditations. There will not be any changes in your curriculum or additional time to graduation due to the change in ownership.

Walden is expected to continue to be a stand-alone institution owned by Adtalem, according to Ulmer. It will keep the same name, and existing students will remain in their degree programs.

For Adtalem, selling DeVry and acquiring Walden is a reputational upgrade, said Trace Urdan, managing director at Tyton Partners, an investment bank and higher education consulting firm. Among for-profits, Walden has a good track record with regulators and is regarded as one of the most spotless actors in the sector, Urdan said.

Generally, investor interest in for-profit institutions has dwindled in recent years, but health care is the one place where people are still interested and investing, said Urdan. Walden has established online nursing programs and mental health programs that are not currently in Adtalems portfolio, he said.

Adtalem seems to be charging deeper into health-care education and going up the value chain, which makes a lot of sense, said Daniel Pianko, partner at University Ventures, a higher education investment firm.

Health-care education is tightly regulated by third parties and job opportunities are plentiful, he said. Some for-profit health-care education programs, particularly in nursing, are considered elite by employers. Demand for health-care professionals nationally is high, said Pianko. He said for-profit education seems to be more accepted in the U.S. for training health-care workers than it is in other fields.

The public sector hasnt been able to produce enough doctors and nurses for our society, especially during COVID, Pianko said. That makes it an area where it makes sense for for-profit institutions and private capital to operate.

While health-care education is a relatively respectable facet of for-profit education, there is a still a risk of increased regulation if a Democratic administration is elected this November, Urdan said. In purchasing Walden University using a mixture of cash on its balance sheet and additional debt, rather than equity, Adtalem is taking a risk, he said.

One of the truisms of managing through a hostile regulatory environment is that you want to have as much cash as possible on hand, Urdan said. This was the lesson of the demise of ITT and Corinthian. Those are both institutions that might still be in existence today if they hadnt spent all their cash.

As of June30, Adtalem had $500.5million in cash and cash equivalents, suggesting the company might need to borrow close to $1billion to close the deal with Walden. The company has also agreed to pay an $88million termination fee to Laureate if the acquisition cannot go through as a result of the imposition by the U.S. Department of Education of certain specified restrictions or if it fails to consummate the transaction upon satisfaction of the closing conditions.

That $88million termination fee is a pretty sizable bet that the U.S. Department of Education wont try to block the deal or require a letter of credit to secure continued access to federal financial aid, said Yan Cao, a fellow at the Century Foundation.

Adtalems acquisition of Walden is concerning to Cao. Under Laureates ownership, Walden was restricted from growing too quickly by regulatory controls imposed by the U.S. Department of Education.

The department imposed those controls because Laureate posted a financial responsibility composite score considered to be in the failing range for at least the last decade, Cao said. The regulatory controls may be lifted when the institution changes ownership, said Cao. Adtalem may have a better financial responsibility composite score than Laureate depending on the amount of debt it takes on, or the U.S. Department of Education might be convinced to consider the composite score of Walden University itself, rather than its parent company, when reviewing the transaction, said Cao.

Adtalems history of failed stewardship in managing DeVry University, an institution that racked up student complaints of fraudulent practices, should be of concern to regulators and Walden University stakeholders, said Cao.

DeVry in December 2016 agreed to pay $100million to settle a lawsuit brought by the Federal Trade Commission alleging the institution misled prospective students about its graduates' job-placement rates. The university denied any wrongdoing. Earlier that year, DeVry announced student protection reforms in response to criticism of the for-profit sector, including voluntarily capping the federal financial aid the institution receives from the U.S. Department of Education.

"DeVry is in the business of democratizing access to education, helping students achieve career goals and being a part of the solution to the workforce skills gap," said Wardell, then president and CEO of DeVry Education Group, in an interview with Inside Higher Ed at the time.

Read more:
Adtalem wagers on Walden University in hopes of building health-care education powerhouse - Inside Higher Ed

TUESDAY on "The Source" The COVID-19 crisis has changed and continues to affect everyday life, including for our pets and for the many animals still in need of a loving home.

More people are working remotely because of health concerns. How has this dynamic affected pet-owner relationships and what happens when it's time to return to the office?

Hurricane season and summer heat can also make life more stressful and dangerous for pets. What precautions should be taken? What should be done for a pet with heat-related illness?

How has the pandemic affected San Antonio animal shelters? What's happening with adoptions and fosters? What is the current level of need?What opportunities are there to volunteer?

What do we know now about whether animals can contract or spread COVID-19? Should owners be doing anything to protect their pets amid the pandemic?

Guests:

"The Source" is a live call-in program airing Mondays through Thursdays from 12-1 p.m. Leave a message before the program at(210) 615-8982. During the live show, call833-877-8255, emailthesource@tpr.org or tweet@TPRSource.

*This interview will be recorded on Tuesday, September 15.

More here:
How Are The Pandemic, Remote Work, Extreme Heat Affecting Our Furry Friends? - Texas Public Radio

TIFTON In March, while the Tifton area was getting hit hard with COVID-19 cases, Dr. Jessica Beier, the medical director of Southwell Laboratories and Medical Director of Quality and Patient Safety, was quarantined at home after returning from a vacation in Chile.

When I got home, I was ready to activate, Beier said. While I was gone, we had used the CDC lab, the state lab, our usual reference lab, and all those labs were becoming overwhelmed. Their turnaround times were starting to increase, and we were looking at people potentially having to wait a week to know whether they had tested positive for COVID-19. Everyone was wondering what we were going to do next, and then I was told by our employee health director that I had traveled to a country that was considered a level three risk.

I was quarantined at home, and it was really not a good time. I brought my microscope and started doing pathology from home. In the midst of all of this, I had a lot of time on my hands to think, and because I have a horse farm, I am well aware that we have a vet diagnostic lab here in Tifton thats part of UGA. I also know that this lab here does high-complexity molecular diagnostic testing because of all of the infectious disease testing they normally do on animals.

Something clicked in Beiers head. Why not partner with UGA and the lab that was right in her own backyard to meet the pandemic head on? Although she had no contacts with anyone at the diagnostic lab, she was able to find the email address for Hemant Naikare, Tifton Veterinary Diagnostic and Investigational Lab director and am associate professor of infectious diseases in the College of Veterinary Medicine and reached out to him.

I remember Dr. Beier reaching out to me on a Saturday at the end of March, Naikare said. She wanted to know if we could assist with COVID testing, so we started correspondence the first week of April. I told her that we had the infrastructure, and we do polymerase chain reaction (PCR) testing, which is an essential component of processing COVID-19 tests. I explained to her that we could help, but our major hurdle was CLIA.

CLIA stands for Clinical Laboratory Improvement Amendments, and for labs to process human samples, they must be registered and certified under CLIA.

One aspect of the UGA College of Veterinary Medicine and TVDILs mission is service to the state. Usually, that means aiding local livestock producers, veterinarians, or companion animal owners in south Georgia but the pandemic provided a unique situation.

I knew that these long turnaround times were a huge problem, especially here in rural Georgia, so I took this issue to my department head, Dr. Jesse Hostetter, and CVM Dean Lisa Nolan, Naikare said. Dr. Beier and Southwell were in need of support, and it was clear to me that we could help. I explained that we had the equipment needed for human testing, and we had the trained personnel. It was just a matter of getting started. With the permission and the right credentials, we could definitely help out.

The TVDIL is able to run an average of about 125 COVID-19 tests per day, many of which are sent over from Southwells drive-thru testing site, and these are processed usually within 24 hours. Most inpatients at Tift Regional Medical Center who need to be tested use a rapid test that is processed through the in-house laboratory there.

Success! An email has been sent to with a link to confirm list signup.

Error! There was an error processing your request.

We can run up to 270 tests per day without impacting our mission of animal testing, Naikare said. Just within the last four weeks, the TVDIL has conducted over 3,000 tests for hospitalized patients, pre-surgical patients, symptomatic patients, potentially exposed individuals, and patients and staff from various healthcare settings. Dr. Yung-Yi Mosley, an assistant professor of infectious diseases in the College of Veterinary Medicine has been instrumental in getting the high-volume COVID-19 PCR testing workflow streamlined at the TVDIL lab.

While the TVDIL was originally testing only samples from Southwell, its staff has also partnered with two other local hospital systems recently: Crisp Regional Health System in Cordele and Colquitt Regional Medical Center in Moultrie.

COVID-19 molecular testing is still in high demand, so we hope to ease the burden on other testing labs in the region by providing rapid and accurate test results, Naikare said. By helping these local health systems attain a quick turnaround testing, we are able to prevent community spread in rural Georgia.

While some veterinary diagnostic labs have pivoted to test human samples and help with turnaround times for COVID-19 testing, it is still a fraction of the laboratories in the country. According to Naikare, who estimates there are at least 65 state or university veterinary diagnostic labs in the country, as of Aug. 7, there were only 18 labs that were testing human samples.

We felt that we could really contribute to human testing, and so we are ahead of the curve, Naikare said. At UGA, One Health is the term used to describe the intersection of human, animal, and environmental health. We are providing diagnostic solutions, and this is One Health in action.

I feel very lucky that we happened to be in the right town with the right lab and the right people to make this happen, Beier said. This has taken a lot of teamwork from everyone involved, and I think this shows how much people care about their community to work together and collaborate like this in a crisis. I am so grateful to all my staff at the TRMC lab who have helped to make this partnership work, and all of us at Southwell are grateful to Dr. Naikare and his entire team for everything they have done and continue to do.

Southwell is a leading health care provider serving 12 counties in south-central Georgia. Tift Regional Medical Center, the flagship hospital, is a 181-bed regional referral center offering signature services in surgery, oncology, cardiovascular care, womens health and more. Southwell comprises TRMC and the TRMC West Campus in Tifton, Southwell Medical Hospital and Southwell Health and Rehabilitation in Adel and more than 30 primary care and specialty clinics located throughout the region. Visit http://www.tiftregional.com for more information.

The UGA College of Veterinary Medicine, founded in 1946, is dedicated to training future veterinarians, conducting research related to animal and human diseases, and to providing veterinary services for animals and their owners. Research efforts are aimed at enhancing the quality of life for animals and people, improving the productivity of poultry and livestock, and preserving a healthy interface between wildlife and people in the environment they share. In addition to the DVM program, the college offers masters, Ph.D., and dual-degree programs for students who want to pursue a career in veterinary medicine or a related field, including public health and biomedical research.

Read more:
Tifton veterinary diagnostic lab pitches in with COVID-19 testing - The Albany Herald

Global Veterinary Medicine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 carries out an extensive market analysis covering market aspects like market trends, growth drivers, constraints, and challenges existing in the market. The report aims to define, describe, and forecast the global Veterinary Medicine market in terms of type, application, and region. The report offers an industry-wide competitive analysis, market segments analysis, individual market share of leading players, and the contemporary market scenario. The most vital elements necessary for analyzing this market are included in the report. The key regions (countries) promising a huge market share for the forecast period are covered in the report. The report gives a precise analysis of market size, trends, share, production, and futuristic developments trends, and present and future market status, and forecast, the outlook from 2020 to 2026.

Market Analysis:

The report explores key regions market potential and advantages, opportunities and challenges, restraints, and risks that key players facing in this industry. The report covers the prominent players in the global Veterinary Medicine market with detailed SWOT analysis, financial overview, and key developments. Other information like company profiles, product picture, and specifications, sales revenue, price, gross margin, market share has also been included. The market report is extensively categorized into different product types, applications, player, and regions. The segmentation included in the report is beneficial for readers to capitalize on the selection of appropriate segments for this sector.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/17516

Essential vendors involved in this report are: Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group, Parnell

In terms of geography, the global Veterinary Medicine market includes regions such as North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

With the list of tables and figures, the report provides key statistics on the condition of the business. The research covers the business overview, market segment, upstream, downstream analysis. The report sheds light on the recent developments and innovations in the market as well as several strategies such as the PESTEL analysis and SWOT analysis. The study report covers all the geographical regions where the competitive landscape exists. Thus global Veterinary Medicine market report helps to identify the key growth countries and regions.

Based on type, the market has been segmented into: Oral, Injection, Other

Based on application, the market has been segmented into: Companion Animals, Livestock Animals

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/17516/global-veterinary-medicine-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2026

Key Factors Involved In the Report:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketsandresearch.biz

See more here:
Global Veterinary Medicine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 - Verdant News

September 11, 2020 Ben Palmer's reads

How will the coronavirus pandemic end? The coronavirus pandemic may be the first pandemic to hit the United States in more than century, but it's far from the first pandemic the world has ever faced. Writing for ABC News, Tegan Taylor looks back at past, similar pandemics, including the 1918 Spanish Flu and the 2009 Swine Flu pandemic, and details how those pandemics came to an endand what they might mean for the current coronavirus crisis.

Why do Americans go to the gym? Americans are flocking back to gyms as the facilities begin to reopen, even as the novel coronavirus remains a threat. Writing for The Atlantic, Amanda Mull looks at why Americans prefer going to the gym as opposed to working out at home, what role the gym plays in American culture, and how physical activity has changed over the past 70 years, evolving from a necessity to a leisure activity.

Can you catch the coronavirus from your dog? Since the coronavirus pandemic first began, the World Organization for Animal Health has recorded at least 20 cases of the virus among individual animals, as well as some outbreaks among groups of animals living in close proximity to each other, the Wall Street Journal's Jason Douglas reports. According to Douglas, public health officials in nearly every case confirmed that the animals had contracted the coronavirus from a human who was infected, and there currently are no recorded cases of animals transmitting the coronavirus to people. Jenny Stavisky, an assistant professor in veterinary medicine and science at the University of Nottingham in England, told Douglas that current evidence suggests humans are unlikely to contract the virus from their pets. "The main message here is that even if pets get it they are unlikely to get sick, and there is so far no evidence that an infected pet can go on and infect a human," she said.

Muscular mice may help scientists unlock the key to preventing muscle and bone lossin space. When astronauts travel to space, they exercise two hours per day to slow down muscle and bone less, NPR's John Hamilton reports. But a study published Tuesday in the journalProceedings of the National Academy of Sciences suggests mice may offer clues on how to preserve muscle and bone mass in people, including those who are on interplanetary journeys. For the study, researchers gave mice that spent a month on the International Space Station a drug that neutralized two naturally occurring substances in micemyostatin and activin Athat typically limit muscle and bone growth. Se-Jin Lee, a professor at The Jackson Laboratory and the University of Connecticut who was involved in the study, said the researchers found "[t]he drug was effective not just in preserving the muscle mass and bone mass, but actually caused the muscles and bones to grow." Based on those findings, the researchers are hopeful that the drug may also help protect astronauts against muscle and bone lossand perhaps even people with weak muscles or easily fractured bones.

See the original post:
Weekend reads: Can you catch the coronavirus from your pet? Probably not, experts say. - The Daily Briefing

New York, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Veterinary Medicine Market by Product, Route of Administration, Animal Type, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 20202027" - https://www.reportlinker.com/p05955108/?utm_source=GNW

The veterinary medicine market accounted for $22,973 million in 2019, and is expected to reach $29,698 million by 2027, registering a CAGR of 4.6% from 2020 to 2027. Veterinary medicine is defined as a drug or other preparations employed in the treatment of animals. Furthermore, other preparations such as vaccines and medicated feed additives are also used to treat various medical conditions in animals. In addition, these medicines include different type of products such as anti-infective drugs, which are used to prevent, kill, or slow the growth of bacteria, fungi and other infection causing organisms. These medicines also include anti-inflammatory drugs, which are routinely used for relief of pain and inflammation associated with osteoarthritis, and other medical conditions in livestock and companion animals. Furthermore, parasiticide is another type of veterinary drug, which are employed in prevention or elimination of external and internal parasites such as fleas, ticks, and worms. Other than drugs, vaccines are also used in treatment of various medical conditions in animals. Some types of veterinary vaccines include inactivated vaccines, attenuated vaccines, and recombinant vaccine. Similarly, medicated feed additives are also used to cure medical conditions in livestock and companion animals. In addition, these different types of drugs are administered to animals through different routes such as oral, parenteral and topical. Furthermore, these drugs are used in treatment of companion animals such as dogs, cats and horses and are also used in treatment of livestock animals such as pigs, dairy cattle, beef cattle, and poultry. The major factors that contribute toward the growth of the veterinary medicine market include rise in number of pet owners and surge in livestock population across the globe. Furthermore, factors such as surge in prevalence of various medical conditions in animals and rise in demand for livestock products also boost growth of the veterinary medicine market. In addition, rise in animal healthcare expenditure is another major factor that fuels growth of the market. However, lack of veterinary infrastructure facilities in underdeveloped nations and stringent regulations associated with medicate feed additives restrict growth of the veterinary medicine market. Conversely, increase in awareness toward animal health offers a lucrative opportunity for the veterinary medicine market. The global veterinary medicine market is segmented on the basis of product, route of administration, animal type, distribution channel, and region to provide a detailed assessment of the market. By product, the market is divided into drugs, vaccines, and medicated feed additives. The drugs segment is further divided into anti-infective, anti-inflammatory, and parasiticide. In addition, the vaccines segment is divided into inactivated vaccines, attenuated vaccines, and recombinant vaccines. Similarly, the medicated feed additives segment is divided into amino acids and antibiotics. By route of administration, the market is classified into oral route, parenteral route, and topical route. By animal type, it is divided into companion animals and livestock animals. By distribution channel, it is classified into veterinary hospitals, veterinary clinics, and pharmacies & drug stores. By region, the veterinary medicine market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA). The major players in the veterinary medicine market are Zoetis, Inc., Merck & Co., Inc. (Intervet International B.V.), Elanco Animal Health, Dechra Pharmaceuticals PLC, Ceva Sant Animale, Virbac., Vetoquinol S.A., Boehringer Ingelheim International GmbH., ADM Animal Nutrition, and Evonik Industries AG.

KEY BENEFITS FOR STAKEHOLDERS This report entails a detailed quantitative analysis along with the current global negative pressure wound therapy devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments. The market size and estimations are based on a comprehensive analysis of key developments in the industry. A qualitative analysis based on innovative products facilitates strategic business planning. The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments By Product o Drugs - Anti-infective - Anti-inflammatory - Parasiticide o Vaccines - Inactivated Vaccines - Attenuated Vaccines - Recombinant Vaccines o Medicated Feed Additives - Amino Acids - Antibiotics By Route of Administration o Oral Route o Parenteral Route o Topical Route By Route of Administration o Oral Route o Parenteral Route o Topical Route By Animal Type o Companion Animals o Livestock Animals

By Distribution Channel o Veterinary Hospital Pharmacies o Retail Veterinary Pharmacies By Region o North America - U.S. - Canada - Mexico o Europe - Germany - France - UK - Italy - Spain - Rest of Europe o Asia-Pacific - Japan - China - India - Australia - South Korea - Rest of Asia-Pacific

o LAMEA - Brazil - Saudi Arabia - South Africa - Rest of LAMEA List of key players profiled in the report: Zoetis, Inc. Merck & Co., Inc. (Intervet International B.V.) Elanco Animal Health Dechra Pharmaceuticals PLC Ceva Sant Animale Virbac. Vetoquinol S.A. Boehringer Ingelheim International GmbH. ADM Animal Nutrition Evonik Industries AG

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request) Pharmgate Inc. Bimedia, Inc.Read the full report: https://www.reportlinker.com/p05955108/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Read more here:
The veterinary medicine market accounted for $22,973 million in 2019, and is expected to reach $29,698 million by 2027, registering a CAGR of 4.6%...

Dr. Anthony S. Johnson, DVM, DACVECC, a leading veterinary professional and current Medical Director of the Veterinary Information Network (VIN), has been spotlighted in a new exclusive interview with Inspirery.

PLAINFIELD, IL / ACCESSWIRE / September 3, 2020 / The interview, which was published on August 27, 2020, can be found here on the official site. Inspirery features exclusive and in-depth interviews with accomplished entrepreneurs and executives from around the world.

The interview covered a broad range of business-related topics, including how Dr. Anthony S. Johnson launched his highly successful career in the veterinary profession, how he currently generates revenue, how he acquired his very first customer, and what marketing and new customer acquisition strategies are generating the most impact and return on investment.

In addition, Dr. Anthony S. Johnson provided insights on what he attributes his success to, what he believes the future holds for his business, what the toughest decision he's made in the last few months was, what advice he would give his younger self, and whether he would be willing to be a mentor to those aspiring to enter or establish themselves in the veterinary emergency and critical care field. Not surprising to anyone who knows him and his generous nature, he responded to this request with an emphatic yes.

Dr. Anthony S. Johnson also listed four business books that have inspired him over the years: Blue Ocean Strategy by Rene Mauborgne and W. Chan Kim, How Doctors Think by Jerome Groopman, The Checklist Manifesto by Atul Gawande, and Thinking, Fast and Slow by Daniel Kahneman. He also shared his enthusiasm about entering his 13th year of teaching an acclaimed and popular online class for new graduate veterinarians, which focuses on the basics of emergency room medicine.

"I have always enjoyed teaching, and am proud of the online course and the thousands of veterinarians that we have helped educate over the years," commented Dr. Anthony S. Johnson, who between 2009 and 2014 served as a Clinical Assistant Professor at Purdue University's College of Veterinary Medicine, where he taught a wide range of undergraduate, graduate and professional-level courses. "I believe that I have a duty and responsibility to give back to the profession by sharing my knowledge and experiences. The field of veterinary medicine is dynamic, and there are many exciting developments on the horizon driven by technologies like artificial intelligence and machine learning."

About Dr. Anthony S. Johnson

Dr. Anthony S. Johnson DVM, DACVECC, is a leading veterinary professional and educator who has filled a myriad of executive-level roles in veterinary centers across the U.S., including Critical Care Specialist, Emergency Department Head, and Co-Head. Currently, he is the Medical Director of the Veterinary Information Network (VIN). Dr. Johnson and his family recently relocated to the Chicago area from Carmel, Indiana. Known for his big smile, open heart, and wonderful sense of humor, when he is not working or spending time with his wife and their three children, Dr. Anthony S. Johnson enjoys occasional forays into woodworking, cooking, wine, reading, and writing. For more information about Anthony S. Johnson, please visit: https://anthonysjohnson.net/

Contact Information:

Anthony S. JohnsonEmail: Tony@VIN.comPhone: 503-522-3837

SOURCE: Dr. Anthony S. Johnson

View source version on accesswire.com: https://www.accesswire.com/604710/Leading-Veterinary-Professional-Dr-Anthony-S-Johnson-Spotlighted-in-New-Exclusive-Interview-with-Inspirery

View original post here:
Leading Veterinary Professional Dr. Anthony S. Johnson Spotlighted in New Exclusive Interview with Inspirery - Yahoo Finance

A Cantonment woman has been charged with animal cruelty after allegedly performing injections on cats and collecting dead animals.

Selena Dunlap, 21, was charged with felony unlicensed practice of veterinary medicine and cruelty to animals.

Escambia County Animal Control responded to a home in the 1300 block of Tate Road after receiving a reported that Dunlap was injecting cats with food.

An animal control officer reported that she could see a couple of cats and dogs inside the home. When she asked about a kitten, Dunlap and her roommates said it was inside the trailer. Eddins asked Dunlap to show her what they were injecting the cat with when Dunlap brought out a bottle of sodium chloride.

When the officer was invited inside to see a kitten, she noted that the home was filled with old food, trash, cigarette butts and a dog kennel covered in blankets. Dunlap was holding the kitten, according to an arrest report, and said she had been giving it sugar water, watered down milk and antibotics.

Dunlap showed the animal control officer a needle she said she bought online, and the officer observed a magazine on a table with the title Secrets To Being a Vet Tech.

The officer said the kitten was not able to hold its head up. It was taken to the Escambia County Animal Shelter for care. It later died.

The report adds back in October 2019, Dunlaps dad contacted animal control stating she was living in a tent in the woods and collected dead animals and had live animals as well. When animal control responded to Dunlaps tent, she stated she had seven dogs and eight cats. Puppies were found covered in fleas.

Animal control removed 12 animals from Dunlap and ordered her to bury the dead animals.

Dunlap remained in the Escambia County Jail with bond set at $6,000.

Continued here:
Animal Control: Cantonment Woman Gave Injections To Kitten That Died; Collected Dead Animals - NorthEscambia.com

The state-of-the-art center steps up to aid the region's adoption network.

When longtime philanthropistsTina and George Skestos, founder of Homewood Corp., started working on a legacy project, they decided to address the troubles of a dog-rescue network burdened with overcrowding and costly medical care. After talking with dean Rustin Moore of the Ohio State University College of Veterinary Medicine, Columbus Humane CEO Rachel Finney and several veterinarians, the Skestoses noticed a problem of supply and demand. In Southern Ohio, rural shelters were overwhelmed by unwanted dogs and their medical care, yet Central Ohios counterparts could not keep up with the demand for adoptions.

It was being solved by putting dogs in a van and taking them from point A to point B, then causing more costs to the system as dogs transferred with health conditions, says Justin McKinniss, acting CEO of Gigis Shelter for Dogs, the Skestoses expansive center. George thought if you put a dollar in the middle of the system, it would save two dollars on each side.

Opened in 2018, the $4 million, 26,000-square-foot complex and its 19-member staff examine and treat up to 1,500 dogs annually. The dogs arrive from six partner shelters and typically spend three days at Gigis before being transferred to one of 17 adoption centers. On day one, they receive medical care. Day two, they are evaluated for their behavior, and on day three, they are spayed and neutered. During their stay, theyre kenneled in four separate wards to minimize the spread of disease. Dogs receive care at the state-of-the-art medical center featuring two surgical suites, two veterinarians, a dental suite, exam rooms, X-ray equipment and an isolated parvovirus treatment clinic.

The newest addition is a behavioral center directed by Meghan Herron, one of only three behavioral vets nationally within the shelter community. Dogs receive training to overcome behavioral issues and prepare them for adoption. The shelter now serves as a nationwide model, earning a spot among this years Petco Unsung Hero award finalists, alongside Gigis Shelter board president Jim Phieffer.

Beyond its own operation, Gigis invests in its partners facilities and equips them with vaccines, medical equipment and training. Gigis is the first of its kind, says Finney, who has worked with Gigis from the start. There were lots of transfer agencies, but this was the first that invested in the source shelters. Its not good enough to remove a dog from a [difficult] situation; its about helping agencies do a better job for all dogs.

Before Gigis, we would import litters of puppies with no medical or behavioral information and find out they had parvovirus once they arrive, says Kelsey Smucker, director of CHA Animal Shelter in Westerville. She explains that they would have to pay thousands of dollars to treat this highly infectious and deadly disease thats especially threatening to puppies. Now, Gigis has the facilitiesto quarantine and treat parvovirus as well as intervene with many other medical conditions.

When Gigis dogs arrive at our shelter, they go right on our adoption floor and often are adopted the first day, says Smucker.

While the shelter has garnered recognition, Tina Skestos says the biggest reward is seeing its adoptees, including several she and her husband pass on neighborhood walks with their Akita, Gigi, the shelters namesake. Its great to see the happy faces on these dogs and the joy they bring to these families, Tina says. All these dogs deserve a chance.

Originally posted here:
Gigis Shelter for Dogs is Coming to the Rescues - Columbus Monthly

Four years ago, a casual hallway conversation between Virginia Tech work buddies Brian Huddleston and Heather Parrish led them to embark on a life-transforming journey.

According to Huddleston, a support technician on the IT team at theVirginia-Maryland College of Veterinary Medicine, Heather and I were work friends. We didnt go to each others houses or know each others families. We talked when we saw each other, but that was about it. I think I once bought her a bag of chips from the vending machine.

In exchange, Parrish, formerly an administrative assistant at the veterinary college who now works at theInstitute for Policy and Governancein theCollege of Architecture and Urban Studies, gave Huddleston one of her kidneys hardly an even trade by any stretch of the imagination.

I remember Brian once mentioning that he had a genetic kidney disorder, said Parrish, who was concerned about her colleague at the time. Huddleston, however, assured her that the disease seemed to be under control.

Doctors had first noticed a problem with Huddlestons kidney function when he was a teenager, but for years, he was able to lead a normal life. The situation took a more serious turn four years ago when a routine checkup revealed worrying changes in Huddlestons kidney function. He altered his diet; and once again, the disease was brought to heel.

I was able to manage things for a long time by being careful, Huddleston said. Despite his best efforts, a bout of Henoch-Schonlein purpura, or HSP, a relatively common illness that typically affects children, sidelined him in early 2019. In most people, HSP resolves on its own after a few weeks, but because of Huddlestons already-compromised kidney function, the disease sent his body into a tailspin.

Kidneys filter out waste and release compounds that regulate the bodys bone health, blood pressure, and creation of red blood cells essential functions. Huddlestons kidneys had lost these crucial filtering abilities.

At that point, my kidneys were just useless bags of fluid, Huddleston said with characteristic wry humor. I was admitted to the hospital, and I started hemodialysis. Even after I was discharged, I had to spend three days a week hooked up to a machine just to stay alive.

The average life expectancy of a person on dialysis is about 10 years. Without a new kidney, the 41-year-old husband might not outlive his eight beloved rescue dogs and cats.

During his illness, Huddleston continued sharing updates on his Facebook page. By then, Parrish had left her job at the veterinary college, but she still stayed in touch with former colleagues through social media.

I saw people posting things on Brians page like Let me know if theres anything I can do to help, and I thought, There is something I can do. If Huddleston were going to survive, he didnt need cheery get-well cards or flowers: He needed a new kidney.

Through online research, Parrish discovered that, typically, more than 110,000 men, women, and children are on the national transplant waiting list and that more than 80 percent of those people are waiting for a new kidney. It was a long line, much too long for her liking.

Parrish reached out to the transplantation team at the University of Virginia (UVA) and began the arduous process of match testing. The early signs were good. Parrish and Huddleston shared a blood type and had compatible antibodies. Further testing revealed that Parrishs kidneys were in tip-top shape.

It was comforting to Parrish to know that even if she and Huddleston werent a match, her donation could start a donor chain allowing her kidney to be matched with someone else while another kidney could then be made available for Huddleston.

Working with Virginia Techs Human Resources, Parrish arranged for paid leave under the Bone Marrow/Organ Donor policy that provides time off to eligible employees donating bone marrow or an organ; in any calendar year, the policy also includes recuperation for up to 30 days. This additional leave, along with solid support from her boss, her co-workers, and her family, eased the way for surgery to be scheduled in March 2020.

Donors and their families do not pay for medical expenses associated with organ and tissue donation. And while much of Huddlestons care was covered by insurance, expenses such as ongoing visits to UVA and a hotel stay for his wife when he was hospitalized in Charlottesville were not.

The staff association at the veterinary college stepped in to help. This is just what we do, said Tami Quesenberry, a licensed veterinary technician who co-chaired a massive fundraising effort, including a goods and services auction that raised nearly $10,000 for Huddleston. The situation brought members of this great big veterinary family together like never before, she said.

Continue reading here:
All That and A Bag of Chips: VA Tech Employee Donates Kidney to Save Co-worker's Life - The Roanoke Star

Veterinary care in the field

The School of Veterinary Medicine was taking care of four-legged patients: more than 1,000 in the field and more than two dozen in the Veterinary Medical Teaching Hospital. Officials said they are purposely trying to do most of their first aid in the field, because they are forced by the pandemic to limit hospital capacity.

On Aug. 25, the Veterinary Emergency Response Team deployed a four-person team one faculty veterinarian and two resident veterinarians, and one student on a search and rescue operation in the Vacaville foothills. The team also performed wellness examinations on animals sheltered in place.

At the campus hospital, the team has treated 11 alpacas, six goats, five horses, three llamas, three cats and two sheep.

Read more about the veterinary schools response to the wildfires.

UC Davis put out the welcome mat Friday, offering short-term emergency housing for campus affiliates including faculty, staff and registered students and their families who had been impacted by evacuations or lost their homes due to the wildfires.

For campus affiliates who need somewhere to stay until evacuation orders are lifted and they can return home, the university is offering stays of up to five days. For campus affiliates who have lost their homes, the university can help explore options for longer-term housing solutions.

UC Davis sustained losses, too, as the LNU Lightning Complex struck four of the universitys natural reserves: Quail Ridge, Stebbins Cold Canyon, Cahill Riparian Preserve and McLaughlin Natural Reserve, all in the vicinity of Lake Berryessa west of Davis.

With access limited, officials had not yet been able to assess the full extent of the damage to facilities and research projects. Shane Waddell, though, has seen some of what happened at Quail Ridge, where he is the reserve director. Fire claimed his home and eight tent cabins.

His family evacuated Aug. 19, while he stayed behind to monitor the fire. As the flames drew closer, he decided to leave but not until he had told his neighbors on the Quail Ridge peninsula it was time to depart for their own safety.

Peggy Fiedler, executive director of the UC Natural Reserve System, said UC reserve managers and stewards up and down the state had been absolutely heroic in their efforts to save life and property.

Read more about what happened at the UC Davis reserves and four other UC reserves.

Read more:
Responding to Record-Setting Wildfires - UC Davis

The University of Georgia once again posted new highs in research and development expenditures, nearly topping the $500 million mark and exceeding last years R&D total by almost 4%, illustrating the rapidly growing research enterprise at UGA.

Fueled by new advancements in infectious diseases, plant sciences, behavioral research, animal health, informatics and many other disciplines, UGA posted $495 million in R&D expenditures in fiscal year 2020, which ended June 30. For six of the past seven years, the university has reported annual increases in R&D, which has grown by 41% during that time.

UGA has focused strategically on growing its research enterprise through faculty hiring initiatives, capital projects dedicated to research (such as the ongoing effort to modernize and expand Science Hill, including the I-STEM Research Building currently under construction), and enhanced administrative support to faculty seeking external research funding.

Growing research and innovation is central to the mission of this university, and the future of the research enterprise at UGA has never been brighter, said President Jere W. Morehead. I am pleased that our strategic investments are paying off, and I look forward to the many life-saving and world-changing advancements that will result.

UGA faculty earned dozens of multi-million-dollar awards last year, including potentially the biggest in the universitys history. Ted Ross, a GRA Eminent Scholar and director of the Center for Vaccines and Immunology in the College of Veterinary Medicine, received a major NIH contract to develop a more effective flu vaccine. Establishing one of several prestigious and multi-institutional Collaborative Influenza Vaccine Innovation Centers, the contract is slated to be worth $130 million over seven years. Once the coronavirus pandemic hit, NIH directed Ross to expand the scope of this project to include the testing of potential COVID-19 vaccines, working with colleagues at both academic and industry labs.

UGA received other eight-figure awards in 2020 as well. Professor David Okech in the School of Social Work was awarded nearly $20 million from the U.S. Department of State to find ways to combat human trafficking. Distinguished Research Professor Jessie Kissinger in the Franklin College of Arts and Sciences received two awards worth a combined $16 million to develop specialized health informatics databases.

These large awards complement thousands of other research grants and contracts, large and small, earned by faculty from across UGAs 17 schools and colleges, nearly a third of which received awards totaling more than $10 million.

The University of Georgias growth in external research funding demonstrates the increasing recognition of our faculty, nationally and internationally, said S.JackHu, senior vice president for academic affairs and provost. In a broad range of fields and often working together across traditional academic disciplines, they are making a positive impact on our state and world.

UGA recently launched its Innovation District initiative in part to capitalize on the universitys research growth and provide new pathways for discoveries to reach the public. In each of the past six years, UGA has been a Top 5 university for the number of new products brought to market. UGA now ranks No. 10 in the nation for innovation impact as measured by the George W. Bush Institute/Opus Faveo Innovation Development.

UGA faculty have made significant progress in expanding their externally funded research activities, which allows us to better serve the citizens of Georgia and the world, said David Lee, vice president for research. I congratulate the faculty on their continuing progress. To maximize the impact of our growing research engine, the university has invested in the expertise and resources to bring new discoveries to market whenever that is appropriate, and the Innovation District is an exciting new example.

See more here:
UGA nears $500M in R&D expenditures in record-breaking year - University of Georgia

Richland WA, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce today that it is expanding Isopet into the equine market by making IsoPet available to treat solid tumors in horses. The most common tumors are equoids and sarcomas. This is an important expansion of Vivos business plan.

Our regional clinic in the state of Missouri for IsoPet therapy has agreed to expand into IsoPet therapy on solid tumors in horses. The initial few therapies will be subsidized, while we fine-tune the details of the treatment technique, but we are confident that IsoPet will be the best option available to treat these tumors.

Dr. Mike Korenko stated, Treating large tumors in large animal is a special challenge, but with our experience on large tumors in small animals we have the data necessary to proceed to this next step. This is a potentially lucrative market as Isopet provides a highly differentiated treatment alternative for horses suffering with solid tumors.

About Vivos Inc. (OTCQB: RDGL)

Vivos Inc. has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals (Isopet) and in humans (Radiogel). Brachytherapy uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area using the companys proprietary hydrogel technology. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows safe delivery of higher doses needed for treating both non-resectable and radiation-resistant cancers.

Radiogel is a hydrogel liquid containing tiny yttrium-90 phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.

Radiogel also has a short half-life delivering more than 90% of its therapeutic radiation within 10 days. This compares favorably to other available treatment options requiring up to six weeks or more to deliver a full course of radiation therapy. Therapy can be safely administered as an out-patient procedure and the patient may return home without subsequent concern for radiation dose to family members. The Isopet Solutions division is using university veterinary hospitals to demonstrate the safety and therapeutic effectiveness for different animal cancers. Testing on feline sarcoma at the Washington State University was completed in 2018 and testing on canine soft tissue sarcomas at the University of Missouri was completed in 2019. In February of 2020, we announced the University of Missouri Veterinary Health Center will serve as a regional clinic for Isopet.

In 2018 the Company obtained confirmation from the FDA Center for Veterinary Medicine that Isopet is classified as a medical device according to its intended use and means by which it achieves its intended purpose. The FDA also reviewed the product labeling which included canine and feline sarcomas as the initial indications for use. The FDA does not require pre-market approval for veterinary devices so no additional approval was required for treating skin cancer, which is the largest market sector. Following the demonstration phase, Vivos is able to generate revenue through the sale of Isopet to University animal hospitals and private veterinary clinics.

Isopet for treating animals uses the same technology as RadioGel for treating humans. The Food and Drug Administration advised using different product names in order to avoid confusion and cross-use.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.

CONTACT:

Vivos Inc.Michael K. Korenko, Sc.D.President & CEOMKorenko@RadioGel.com

See the original post here:
Vivos Inc Initiates IsoPet Therapy of Horses Addressing Unmet Need for the Treatment of Equine Tumors - GlobeNewswire

RESEARCH TRIANGLE PARK With $814,714 in initial federal funding,RTI InternationalandDuke Universitys Human Vaccine Institutewill collaborate in a global project to identify viruses and other pathogens in wildlife that could cause disease in people, such as the coronavirus responsible for the COVID-19 pandemic.

RTI and Duke will operate the Coordinating Center for 10 other newly established Centers for Research in Emerging Infectious Diseases(CREID), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The agency awarded 11 grants with a total first-year value of about $17 million to establish the centers and will provide about $82 million over five years to support them.

The impact of the COVID-19 pandemic serves as a potent reminder of the devastation that can be wrought when a new virus infects humans for the first time, said NIAID Director Anthony S. Fauci, M.D. The CREID network will enable early warnings of emerging diseases wherever they occur, which will be critical to rapid responses. The knowledge gained through this research will increase our preparedness for future outbreaks.

CREID will be part of global network of multidisciplinary investigations into how and where viruses and other pathogens emerge from wildlife and cross into humans to cause disease.

Each center in the network will involve collaborations with peer institutions in the United States and 28 other countries. Research projects will include surveillance studies to identify previously unknown causes of febrile (fever-creating) illnesses in humans; find the animal sources of viral or other disease-causing pathogens; and determine which genetic or other changes make these pathogens capable of infecting humans.

CREID investigators also will develop reagents and diagnostic assays to improve detection of emerging pathogens and study human immune responses to new or emerging infectious agents.

The breadth of research projects in the CREID network will allow for study of disease spillover in multiple phases of the process: where pathogens first emerge from an animal host; at the borders between wild and more populated areas, where human-to-human transmission occurs; and, finally, in urban areas, where epidemic spread can occur.

Each CREID center will focus efforts on one or more regions of the world. In Central and South America, for example, studies will include investigations of several arthropod-borne viruses (arboviruses) including the ones that cause Zika virus disease, chikungunya and dengue. In East and Central Africa, focus pathogens will include Rift Valley fever virus and the coronavirus that causes Middle East respiratory syndrome. In West Africa, in addition to arboviruses, projects are slated on Ebola virus and Lassa virus. In Asia and Southeast Asia, investigators will conduct research on coronaviruses and arboviruses.

In every region, investigators will be poised to study any newly emerging pathogen, dubbed pathogen X.

The CREID Coordinating Center run by RTI and Duke will support network-wide activities such as data management, outbreak research response and quality control for biospecimens, assays and reagents. It will also administer a pilot research program for early career investigators.

The principal investigators for the CREID Coordinating Center will be Donald Brambilla, Ph.D., of RTI and Tony Moody, M.D., of Dukes School of Medicine.

Our ability to support rapid and efficient research response to an emerging infectious disease outbreak is paramount to shortening the duration and reducing morbidity and mortality, said Brambilla, senior research statistician at RTI.

Moody, associate professor of pediatrics at Duke, said, During the past six months, weve seen the impact of the COVID-19 pandemic across the globe. By creating and supporting an infrastructure that allows rapid response to infectious disease outbreaks by researchers and by leveraging what we have learned and are learning from research organizations across the globe, we aim to shorten future outbreaks.

As the operational hub for the CREID Network, the RTI-Duke Coordinating Center team offers expertise in supporting administration and management of data and scientific programs, according to the CREID website. The CREID CC has extensive experience in international outbreak research response, including field experience responding to complex outbreaks.

The RTI-Duke team will also maintain and grow existing relationships with domestic and international collaborators, including Ministries of Health and local research institutions, according to the website. Additionally, the team will facilitate and coordinate relevant outreach to engage new partners.

The RTI-Duke team will support 10 CREID centers based at Scripps Research Institute; EcoHealth Alliance; University of California, Berkeley; University of California, Davis, School of Veterinary Medicine; Washington State University; Institut Pasteur; University of Texas Medical Branch, Galveston; University of Washington, Seattle; Washington University School of Medicine; and the University of Texas Medical Branch, Galveston.

(C) N.C. Biotech Center

Read the original:
RTI, Duke team up to identify threats like coronavirus in wildlife that might affect humans - WRAL Tech Wire

In an effort to safeguard the health and safety of all during the COVID-19 pandemic, the Human Animal Bond Research Institute (HABRI) has transformed its annual Pet Night on Capitol Hill to a virtual week-long event. Now called Pet Week on Capitol Hill, the event will take place Sept. 8-10.

Pets have become even more important during the coronavirus pandemic, said Steven Feldman, executive director of HABRI. Pet Week on Capitol Hill will feature conversations with members of Congress and pet care leaders about the importance of pet ownership in America.

The first night will include a session about the importance of pets in America, presented by Feldman and Mark Cushing, author of Pet Nation: The Love Affair That Changed America.

The session, Lifesaving Pet-Related Legislation: A Discussion of Important Initiatives That Will Help Keep Pets and People Safe, Healthy and Happy Together, will take place the following day on Sept. 9. Presenters include Kurt Venator, DVM, Ph.D., chief veterinary officer at Nestl Purina PetCare; Nicole Forsyth, president and CEO of RedRover; and Nicole Lanahan, executive director of Got Your Six Support Dogs.

Also taking place that evening is the session One Health Act: The Role of Veterinary Medicine in Preventing Future Pandemics, presented by Representative Kurt Schrader (OR-5).

On Sept. 10, Steven King, president and CEO of American Pet Products Association (APPA), and Dave Bolen, industry specialist at Graham Partners, will present Pet Ownership and Pet Industry Economics in the Post-COVID World.

Following, Susanne Kogut, president of the Petco Foundation, will present COVID-19 Impact on Pet Fostering and Adoption. The Animal Health Institute (AHI) will then present Cutest Pets on Capitol Hill: Honoring the Cutest Congressional Companions from Both Sides of the Aisle.

We plan to be back with Pet Night on Capitol Hill next year to celebrate in person with the pets that we love so much, Feldman said. Until then, we hope that virtual Pet Week will be helpful, and that all of the participating pet care organizations will serve as valuable resources for our friends on Capitol Hill.

Details on Pet Week on Capitol Hill can be found here.

Read more on PPN's coverage of this topic:

Continue reading here:
Pets to Take on Capitol Hill in Virtual Week-Long Event - PetProductNews.com

Science's COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation

Vacationers on the beach in Tamariu, on Spain's Costa Brava, on 17 August.

We're at risk of gambling away our success, virologist Christian Drosten warned in the German newspaper Die Zeit earlier this month. His message referred to Germany, but it could have been addressed to all of Europe. After beating back COVID-19 in the spring, most of Europe is seeing a resurgence. Spain is reporting close to 10,000 cases a day, more than it had at the height of the outbreak in the spring. France is back to reporting thousands of cases a day. In Germany, numbers are still low, but rising steadily. The pandemic is affecting countries that saw few cases in the spring, such as Greece and Malta, but is also rebounding in places that suffered terribly, including the cities of Madrid and Barcelona.

Drosten, of the Charit University Hospital in Berlin, is one of many calling for renewed vigilance, and he and others are urging a new control strategy that trades blanket lockdowns for measures specifically targeting clusters of cases, which play a key role in spreading the coronavirus. We successfully aborted the [first] wave and now we should make sure that no new wave builds, epidemiologist Christian Althaus of the University of Bern says.

Few dispute that Europe rose to the initial challenge. In Bergamo, the capital of Italy's Lombardy region, crematoria were so overburdened in March that army trucks had to transport the dead to other citiesbut on 24 May, Lombardy registered zero COVID-19 deaths for the first time. By early July, the European Union and the United Kingdom together averaged fewer than 5000 new cases per day, whereas the United States and Brazil (which together have roughly the same population) had 50,000 and 40,000, respectively. Europeans enjoyed a surprisingly normal summer, with northern Europeans flocking to Mediterranean beaches.

The rising case numbers today aren't quite comparable to the peak in April because countries are now testing far more people on a daily basis. But the increase shows that Europe relaxed measures too early and too much, says virologist Ab Osterhaus of the University of Veterinary Medicine in Hanover, Germany. The wrong message was given, basically: We have done a great job and now we can relax again. Instead, Europe could have tried to emulate New Zealand by stopping community transmission completely and zealously guarding against reintroductions, says Devi Sridhar, a global health expert at the University of Edinburgh who has been advising the Scottish government. Scotland committed early on to pushing case numbers down to zero, but other countries did not, and now almost all are seeing a resurgence.

People's willingness to stay alert and remember new rules wanes quickly, says Cornelia Betsch, a psychologist at the University of Erfurt who has been monitoring attitudes toward the pandemic in Germany. And we have been going for a while now, and the end is not even clear. Some countries saw workplace infections rise as people returned to their offices, says Gianfranco Spiteri, a public health expert at the European Centre for Disease Prevention and Control. But in many countries the resurgence is driven by young people partying and basically people living their life back in a kind of normal way, he says. Because new cases are younger, fewer of them die, but it's a matter of time before the elderly are affected, Spiteri says. The reopening of schools across the continent may make matters worse.

As in the spring, every country has its own strategies for controlling the pandemic, leading to a sometimes confusing patchwork. Belgium has one of the strictest face mask policies, for instance, but Belgians crossing the Dutch border to shop in Maastricht can take off their masks. Even within countries, the rules can change at dizzying speed. Germany went from a mandatory 14-day quarantine for people arriving from countries considered risky to voluntary tests at the airport and other entry points, with no quarantine for those who tested negative. Next, it made the tests mandatory, then returned to mandatory quarantine with testing after 5 days. What would be necessary is that we define one central policy in Europe, Osterhaus says. The problem is, who is going to do that? The European Union has little power to coordinate health measures.

Yet countries are better prepared this time. Whereas the virus spread largely under the radar in February, widespread testing now reveals its movements. (Fewer than 3% of tests are positive in most European countries, a sign of a healthy testing capacity.) Face masks, not available or even recommended in the beginning, have become ubiquitous in most countries. More than a dozen EU countries have developed apps to help contact tracing efforts. Better treatments are saving lives.

Meanwhile, new insights into viral spread are leading to better targeted control measures. The emphasis on hand hygiene is gone because it has become clear that contaminated surfaces don't play a large role. In the spring, some countries banned almost any outdoor activity, including jogging; now, the focus is on indoor activities. We've learned outdoor hospitality is generally fine, nonessential shops are fine as long as people wear face coverings, public transport doesn't seem that risky, Sridhar says.

Instead, public health experts increasingly argue for targeting clusters of cases and superspreading events. Some studies estimate that 10% of patients cause 80% of all infections, whereas most don't infect anybody at all (Science, 22 May, p. 808). Drosten has urged that contact tracers spend more time finding the source of a new casealong with that person's contactsthan the new case's contacts; after all, the patient may not infect anybody else, but is likely to have caught the virus as part of a cluster, Drosten says.

Adam Kucharski, a disease modeler at the London School of Hygiene & Tropical Medicine, agrees. Looking backwards can actually give you a disproportionate benefit in terms of identifying infections, he says. In a recent preprint, Kucharski and his colleagues estimated that backward contact tracing could prevent twice as many infections as tracing contacts forward alone. Experience in South Korea, where clusters at churches drove the epidemic early on, confirmed the value of this approach, says University of Florida biostatistician Natalie Dean.

Putting more effort into finding clusters should also help epidemiologists understand where and how they emerge, says Hitoshi Oshitani of Tohoku University in Japanwhich may have changed since the spring. We've seen a massive change in the social structure and interactions of populations from the start of the pandemic, Kucharski says. The conditions that spread the virus then won't necessarily be the same ones that are creating the risk now. In Germany, for instance, many large outbreaks early in the pandemic occurred in long-term care facilities. Now, clusters are increasingly reported from workplaces.

More-targeted measures probably won't be enough to keep the virus from resurging, Althaus says. A point will be reached again where stricter measures have to be taken, he says. But rather than complete lockdowns, he assumes they will be more like the lighter version applied in Sweden, which encouraged people to work from home and banned large gatherings while keeping shops and restaurants open. Scotland recently closed pubs and restaurants in Aberdeen for more than 2 weeks after a cluster of cases emerged; it asked inhabitants not to travel more than 8 kilometers outside the city and visitors to stay away. But schools remained open.

Compared with the United States, Europe has one advantage as it faces its first pandemic winter: Control measures aren't nearly as controversial. Protests against masks and social distancing broke out in many European cities in August, but they represented a small minority of the population, Betsch says. In Germany, support for control measures declined somewhat after infections peaked in spring, but a large majority still backs them, Betsch says. And with case numbers back on the rise, she says, We can already see acceptance numbers go up again.

Link:
Can Europe tame the pandemic's next wave? - Science